BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990;172:599-607. [PMID: 2165128 DOI: 10.1084/jem.172.2.599] [Cited by in Crossref: 277] [Cited by in F6Publishing: 286] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 1994;24:2699-705. [DOI: 10.1002/eji.1830241119] [Cited by in Crossref: 127] [Cited by in F6Publishing: 125] [Article Influence: 4.5] [Reference Citation Analysis]
2 Huaux F, Arras M, Vink A, Renauld J, Lison D. Soluble Tumor Necrosis Factor (TNF) Receptors p55 and p75 and Interleukin-10 Downregulate TNF- α Activity during the Lung Response to Silica Particles in NMRI Mice. Am J Respir Cell Mol Biol 1999;21:137-45. [DOI: 10.1165/ajrcmb.21.1.3570] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
3 Hayashida K, Bartlett AH, Chen Y, Park PW. Molecular and cellular mechanisms of ectodomain shedding. Anat Rec (Hoboken) 2010;293:925-37. [PMID: 20503387 DOI: 10.1002/ar.20757] [Cited by in Crossref: 120] [Cited by in F6Publishing: 110] [Article Influence: 10.0] [Reference Citation Analysis]
4 Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CWG. Interleukin-6, turnour necrosis factor and soluble turnour necrosis factor receptors in women with pre-eclampsia. BJOG:An international journal of O&G 1995;102:20-5. [DOI: 10.1111/j.1471-0528.1995.tb09020.x] [Cited by in Crossref: 292] [Cited by in F6Publishing: 279] [Article Influence: 10.8] [Reference Citation Analysis]
5 McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos CI, Mulley J, Quane KA, Molloy MG, Ranki A, Powell RJ, Hitman GA, O'Shea JJ, Kastner DL. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133-44. [PMID: 10199409 DOI: 10.1016/s0092-8674(00)80721-7] [Cited by in Crossref: 897] [Cited by in F6Publishing: 271] [Article Influence: 39.0] [Reference Citation Analysis]
6 Kalinkovich A, Engelmann H, Harpaz N, Burstein R, Barak V, Kalickman I, Wallach D, Bentwich Z. Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol 1992;89:351-5. [PMID: 1325303 DOI: 10.1111/j.1365-2249.1992.tb06961.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 1.9] [Reference Citation Analysis]
7 Dambuza IM, Keeton R, Hsu NJ, Allie N, Quesniaux VF, Ryffel B, Jacobs M. Persistent p55TNFR expression impairs T cell responses during chronic tuberculosis and promotes reactivation. Sci Rep 2016;6:39499. [PMID: 27995986 DOI: 10.1038/srep39499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
8 Montes-de-Oca M, Blanco MJ, Marquez M, Soto MJ, Fernandez-Gutiérrez C, Rodriguez-Ramos C, Giron-Gonzalez JA. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation. Liver Int. 2011;31:850-858. [PMID: 21645216 DOI: 10.1111/j.1478-3231.2011.02505.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
9 Stadlbauer V, Mookerjee RP, Hodges S, Wright GA, Davies NA, Jalan R. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol. 2008;48:945-951. [PMID: 18433921 DOI: 10.1016/j.jhep.2008.02.015] [Cited by in Crossref: 173] [Cited by in F6Publishing: 171] [Article Influence: 12.4] [Reference Citation Analysis]
10 Su T, Chang K, Lee C, Chen C, Yang Y, Shieh T. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma. Oral Oncology 2004;40:804-10. [DOI: 10.1016/j.oraloncology.2004.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
11 Brakebusch C, Varfolomeev E, Batkin M, Wallach D. Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor. Journal of Biological Chemistry 1994;269:32488-96. [DOI: 10.1016/s0021-9258(18)31661-2] [Cited by in Crossref: 58] [Article Influence: 2.1] [Reference Citation Analysis]
12 Kepler TB, Chan C. Spatiotemporal programming of a simple inflammatory process. Immunol Rev 2007;216:153-63. [PMID: 17367341 DOI: 10.1111/j.1600-065X.2007.00500.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
13 Trefzer U, Brockhaus M, Lötscher H, Parlow F, Budnik A, Grewe M, Christoph H, Kapp A, Schöpf E, Luger TA. The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J Clin Invest 1993;92:462-70. [PMID: 8392091 DOI: 10.1172/JCI116589] [Cited by in Crossref: 78] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
14 Roghani M, Becherer JD, Moss ML, Atherton RE, Erdjument-Bromage H, Arribas J, Blackburn RK, Weskamp G, Tempst P, Blobel CP. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J Biol Chem 1999;274:3531-40. [PMID: 9920899 DOI: 10.1074/jbc.274.6.3531] [Cited by in Crossref: 241] [Cited by in F6Publishing: 226] [Article Influence: 10.5] [Reference Citation Analysis]
15 Elborn JS, Delamare F, Bell SC, Shale DJ. Can tumor necrosis factor-α (TNF-α) be reliably measured in blood? Pediatr Pulmonol 1995;19:226-30. [DOI: 10.1002/ppul.1950190407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
16 Kalinkovich A, Livshits G, Engelmann H, Harpaz N, Burstein R, Kaminsky M, Wallach D, Bentwich Z. Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes. Clin Exp Immunol 1993;93:350-5. [PMID: 8396513 DOI: 10.1111/j.1365-2249.1993.tb08184.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
17 Díaz-Rodríguez E, Montero JC, Esparís-Ogando A, Yuste L, Pandiella A. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol Biol Cell 2002;13:2031-44. [PMID: 12058067 DOI: 10.1091/mbc.01-11-0561] [Cited by in Crossref: 231] [Cited by in F6Publishing: 229] [Article Influence: 11.6] [Reference Citation Analysis]
18 Gasparini C, Menegazzi R, Patriarca P, Dri P. Evidence that elastase is the TNF-R75 shedding enzyme in resting human polymorphonuclear leukocytes. FEBS Lett 2003;553:360-4. [PMID: 14572651 DOI: 10.1016/s0014-5793(03)01046-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
19 Ehlers MRW, Riordan JF. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry 1991;30:10065-74. [DOI: 10.1021/bi00106a001] [Cited by in Crossref: 189] [Cited by in F6Publishing: 218] [Article Influence: 9.5] [Reference Citation Analysis]
20 Chen A, Engel P, Tedder TF. Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes. J Exp Med 1995;182:519-30. [PMID: 7543141 DOI: 10.1084/jem.182.2.519] [Cited by in Crossref: 119] [Cited by in F6Publishing: 113] [Article Influence: 4.4] [Reference Citation Analysis]
21 Fritz S, Striggow F, Reinhold D, Schlüter T, Schönfeld P, Ansorge S, Bohnensack R. Phorbol ester-induced shedding of intercellular adhesion molecule-1 (ICAM-1) on erythroleukemic K 562 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1996;1312:255-61. [DOI: 10.1016/0167-4889(96)00039-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
22 Derouich-guergour D, Aldebert D, Vigan I, Jouvin-marche E, Marche PN, Aubert D, Ambroise-thomas P, Pelloux H. Toxoplasma gondii infection can regulate the expression of tumour necorsis factor-alpha receptors on human cell in vitro. Parasite Immunol 2002;24:271-9. [DOI: 10.1046/j.1365-3024.2002.00462.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
23 Tedder TF. Cell-surface receptor shedding: a means of regulating function. Am J Respir Cell Mol Biol 1991;5:305-6. [PMID: 1654954 DOI: 10.1165/ajrcmb/5.4.305] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 1.0] [Reference Citation Analysis]
24 Engelberts I, Stephens S, Francot G, Van Der Linden C, Buurman W. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. The Lancet 1991;338:515-6. [DOI: 10.1016/0140-6736(91)90591-c] [Cited by in Crossref: 110] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
25 Kawahara R, Granato DC, Yokoo S, Domingues RR, Trindade DM, Paes Leme AF. Mass spectrometry-based proteomics revealed Glypican-1 as a novel ADAM17 substrate. J Proteomics 2017;151:53-65. [PMID: 27576135 DOI: 10.1016/j.jprot.2016.08.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
26 Mackowiak PA. Temperature Regulation and the Pathogenesis of Fever. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 763-78. [DOI: 10.1016/b978-0-443-06839-3.00050-3] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Kapp A, Komann A, Sch�pf E. Effect of tumour necrosis factor alpha in vivo on human granulocyte oxidative metabolism. Arch Dermatol Res 1991;283:362-5. [DOI: 10.1007/bf00371816] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Schleiffenbaum B, Olgiati L, Fehr J. TNF-specific deactivation of granulocytes in vivo: A possible mechanism of self-protection. European Journal of Haematology 1992;49:239-45. [DOI: 10.1111/j.1600-0609.1992.tb00055.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
29 Wiedermann FJ, Mayr AJ, Hobisch-Hagen P, Fuchs D, Schobersberger W. Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. J Interferon Cytokine Res 2003;23:729-36. [PMID: 14769149 DOI: 10.1089/107999003772084842] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
30 Dayer J, Fenner H. The role of cytokines and their inhibitors in arthritis. Baillière's Clinical Rheumatology 1992;6:485-516. [DOI: 10.1016/s0950-3579(05)80186-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
31 Verschure PJ, van Marle J, Joosten LA, van den Berg WB. Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally induced arthritis. Ann Rheum Dis 1995;54:645-53. [PMID: 7677441 DOI: 10.1136/ard.54.8.645] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
32 Yamashita K, Takahashi A, Kobayashi S, Hirata H, Mesner PW, Kaufmann SH, Yonehara S, Yamamoto K, Uchiyama T, Sasada M. Caspases Mediate Tumor Necrosis Factor-–Induced Neutrophil Apoptosis and Downregulation of Reactive Oxygen Production. Blood 1999;93:674-85. [DOI: 10.1182/blood.v93.2.674] [Cited by in Crossref: 95] [Article Influence: 4.1] [Reference Citation Analysis]
33 Coyne C, Baravick J, Howell T, Baravick E, Willetto C, Fenwick BW. Biochemical mechanisms that interact with membrane-associated IL-1 RII (60-kDa decoy) receptors in populations of adherent macrophages and vascular endothelium. Cellular Signalling 2001;13:765-76. [DOI: 10.1016/s0898-6568(01)00196-6] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
34 Bosenberg MW, Pandiella A, Massagué J. The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGF alpha into soluble growth factor. Cell 1992;71:1157-65. [PMID: 1473151 DOI: 10.1016/s0092-8674(05)80064-9] [Cited by in Crossref: 92] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
35 Salamone G, Giordano M, Trevani AS, Gamberale R, Vermeulen M, Schettinni J, Geffner JR. Promotion of neutrophil apoptosis by TNF-alpha. J Immunol 2001;166:3476-83. [PMID: 11207306 DOI: 10.4049/jimmunol.166.5.3476] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 3.4] [Reference Citation Analysis]
36 Arribas J, Massagué J. Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. J Cell Biol 1995;128:433-41. [PMID: 7844156 DOI: 10.1083/jcb.128.3.433] [Cited by in Crossref: 109] [Cited by in F6Publishing: 117] [Article Influence: 4.0] [Reference Citation Analysis]
37 Wang P, Yu P, Gao P, Shi T, Ma D. Discovery of novel human transcript variants by analysis of intronic single-block EST with polyadenylation site. BMC Genomics 2009;10:518. [PMID: 19906316 DOI: 10.1186/1471-2164-10-518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
38 Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol. 1993;54:271-335. [PMID: 8379464 DOI: 10.1016/s0065-2776(08)60537-4] [Cited by in Crossref: 739] [Cited by in F6Publishing: 190] [Article Influence: 25.5] [Reference Citation Analysis]
39 Ertel W, Keel M, Bonaccio M, Steckholzer U, Gallati H, Kenney JS, Trentz O. Release of Anti-inflammatory Mediators after Mechanical Trauma Correlates with Severity of Injury and Clinical Outcome: . The Journal of Trauma: Injury, Infection, and Critical Care 1995;39:879-87. [DOI: 10.1097/00005373-199511000-00011] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 2.7] [Reference Citation Analysis]
40 Bertok S, Wilson MR, Dorr AD, Dokpesi JO, O'Dea KP, Marczin N, Takata M. Characterization of TNF receptor subtype expression and signaling on pulmonary endothelial cells in mice. Am J Physiol Lung Cell Mol Physiol 2011;300:L781-9. [PMID: 21378027 DOI: 10.1152/ajplung.00326.2010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
41 Grenz A, Schenk M, Zipfel A, Viebahn R. TNF-alpha and its receptors mediate graft rejection and loss after liver transplantation. Clin Chem Lab Med. 2000;38:1183-1185. [PMID: 11156356 DOI: 10.1515/cclm.2000.184] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
42 Kotone-Miyahara Y, Yamashita K, Lee KK, Yonehara S, Uchiyama T, Sasada M, Takahashi A. Short-term delay of Fas-stimulated apoptosis by GM-CSF as a result of temporary suppression of FADD recruitment in neutrophils: evidence implicating phosphatidylinositol 3-kinase and MEK1-ERK1/2 pathways downstream of classical protein kinase C. J Leukoc Biol 2004;76:1047-56. [PMID: 15328334 DOI: 10.1189/jlb.0104048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
43 Ninomiya JT, Bi Y, Banks MA, Lavish SA, Goldberg VM, Greenfield EM. Bone marrow cells produce soluble factors that inhibit osteoclast activity. J Orthop Res 1999;17:51-8. [DOI: 10.1002/jor.1100170109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
44 Loetscher H, Gentz R, Zulauf M, Lustig A, Tabuchi H, Schlaeger E, Brockhaus M, Gallati H, Manneberg M, Lesslauer W. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity. Journal of Biological Chemistry 1991;266:18324-9. [DOI: 10.1016/s0021-9258(18)55273-x] [Cited by in Crossref: 70] [Article Influence: 2.3] [Reference Citation Analysis]
45 de Oca Arjona MM, Marquez M, Soto MJ, Rodriguez-Ramos C, Terron A, Vergara A, Arizcorreta A, Fernandez-Gutierrez C, Giron-González JA. Bacterial translocation in HIV-infected patients with HCV cirrhosis: implication in hemodynamic alterations and mortality. J Acquir Immune Defic Syndr. 2011;56:420-427. [PMID: 21266909 DOI: 10.1097/qai.0b013e31820ef408] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
46 Pang X, Ross NS, Hershman JM. Alterations in TNF-α Signal Transduction in Resistant Human Papillary Thyroid Carcinoma Cells. Thyroid 1996;6:313-7. [DOI: 10.1089/thy.1996.6.313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
47 Fishman M. Cytolytic activities of activated macrophages versus paraformaldehyde-fixed macrophages; soluble versus membrane-associated TNF. Cellular Immunology 1991;137:164-74. [DOI: 10.1016/0008-8749(91)90066-k] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
48 Mantovani A, Vecchi A, Sozzani S, Sica A, Allavena P. Tumors as a Paradigm for the In Vivo Role of Chemokines in Leukocyte Recruitment. In: Rollins BJ, editor. Chemokines and Cancer. Totowa: Humana Press; 1999. pp. 35-49. [DOI: 10.1007/978-1-59259-701-7_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
49 Akkose S, Ozgurer A, Bulut M, Koksal O, Ozdemír F, Ozguç H. Relationships between markers of inflammation, severity of injury, and clinical outcomes in hemorrhagic shock. Adv Ther 2007;24:955-62. [PMID: 18029320 DOI: 10.1007/BF02877699] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
50 Pelletier J, Dibattista JA, Roughley P, Mccollum R, Martel-pelletier J. CYTOKINES AND INFLAMMATION IN CARTILAGE DEGRADATION. Rheumatic Disease Clinics of North America 1993;19:545-68. [DOI: 10.1016/s0889-857x(21)00331-8] [Cited by in Crossref: 46] [Article Influence: 1.6] [Reference Citation Analysis]
51 Hecht JL, Fichorova RN, Tang VF, Allred EN, McElrath TF, Leviton A; Elgan Study Investigators. Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns. Pediatr Res 2011;69:68-73. [PMID: 20921924 DOI: 10.1203/PDR.0b013e3181fed334] [Cited by in Crossref: 74] [Cited by in F6Publishing: 56] [Article Influence: 6.7] [Reference Citation Analysis]
52 Zhao L, Shey M, Farnsworth M, Dailey MO. Regulation of Membrane Metalloproteolytic Cleavage of L-selectin (CD62L) by the Epidermal Growth Factor Domain. Journal of Biological Chemistry 2001;276:30631-40. [DOI: 10.1074/jbc.m103748200] [Cited by in Crossref: 58] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
53 Beyaert R, Fiers W. Tumor Necrosis Factor and Lymphotoxin. Cytokines. Elsevier; 1998. pp. 335-60. [DOI: 10.1016/b978-012498340-3/50025-7] [Cited by in Crossref: 27] [Article Influence: 1.1] [Reference Citation Analysis]
54 Faist E, Angele MK, Zedler S. Immunoregulation in Shock, Trauma, and Sepsis. In: Marshall JC, Cohen J, editors. Immune Response in the Critically Ill. Berlin: Springer Berlin Heidelberg; 2000. pp. 312-34. [DOI: 10.1007/978-3-642-57210-4_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
55 Dai H, Guzman J, Chen B, Costabel U. Production of Soluble Tumor Necrosis Factor Receptors and Tumor Necrosis Factor-α by Alveolar Macrophages in Sarcoidosis and Extrinsic Allergic Alveolitis. Chest 2005;127:251-6. [DOI: 10.1378/chest.127.1.251] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
56 Mullberg J, Schooltink H, Stoyan T, Gunther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose-John S. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol. 1993;23:473-480. [PMID: 8436181 DOI: 10.1002/eji.1830230226] [Cited by in Crossref: 342] [Cited by in F6Publishing: 345] [Article Influence: 11.8] [Reference Citation Analysis]
57 Xia M, Xue SB, Xu CS. Shedding of TNFR1 in regenerative liver can be induced with TNF α and PMA. World J Gastroenterol 2002; 8(6): 1129-1133 [PMID: 12439939 DOI: 10.3748/wjg.v8.i6.1129] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
58 Higuchi M, Aggarwal B. Okadaic acid induces down-modulation and shedding of tumor necrosis factor receptors. Comparison with another tumor promoter, phorbol ester. Journal of Biological Chemistry 1993;268:5624-31. [DOI: 10.1016/s0021-9258(18)53366-4] [Cited by in Crossref: 24] [Article Influence: 0.8] [Reference Citation Analysis]
59 Serra-pages C, Saito H, Streuli M. Mutational analysis of proprotein processing, subunit association, and shedding of the LAR transmembrane protein tyrosine phosphatase. Journal of Biological Chemistry 1994;269:23632-41. [DOI: 10.1016/s0021-9258(17)31562-4] [Cited by in Crossref: 36] [Article Influence: 1.3] [Reference Citation Analysis]
60 Parmely MJ, Sterner KE, Gale A, Zhou W. U937 Cells Can Utilize Plasminogen Activator to Regulate Human Interferon-γ. Journal of Interferon Research 1993;13:397-406. [DOI: 10.1089/jir.1993.13.397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
61 Olson NC, Hellyer PW, Dodam JR. Mediators and vascular effects in response to endotoxin. Br Vet J 1995;151:489-522. [PMID: 8556312 DOI: 10.1016/s0007-1935(05)80023-5] [Cited by in Crossref: 69] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
62 Waetzig GH, Rosenstiel P, Arlt A, Till A, Bräutigam K, Schäfer H, Rose-John S, Seegert D, Schreiber S. Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1. FASEB J 2005;19:91-3. [PMID: 15514103 DOI: 10.1096/fj.04-2073fje] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 3.9] [Reference Citation Analysis]
63 Loenen WA, De Vries E, Gravestein LA, Hintzen RQ, Van Lier RA, Borst J. The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur J Immunol 1992;22:447-55. [PMID: 1311261 DOI: 10.1002/eji.1830220224] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 2.0] [Reference Citation Analysis]
64 Jensen LE, Whitehead AS. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J. 1998;334:489-503. [PMID: 9729453 DOI: 10.1042/bj3340489] [Cited by in Crossref: 270] [Cited by in F6Publishing: 265] [Article Influence: 11.3] [Reference Citation Analysis]
65 Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta 2014;1843:2563-82. [PMID: 24892271 DOI: 10.1016/j.bbamcr.2014.05.014] [Cited by in Crossref: 816] [Cited by in F6Publishing: 762] [Article Influence: 102.0] [Reference Citation Analysis]
66 Hensler T, Sauerland S, Bouillon B, Raum M, Rixen D, Helling HJ, Andermahr J, Neugebauer EA. Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase. J Trauma 2002;52:962-70. [PMID: 11988666 DOI: 10.1097/00005373-200205000-00023] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.0] [Reference Citation Analysis]
67 Kiessling LL, Gordon EJ. Transforming the cell surface through proteolysis. Chemistry & Biology 1998;5:R49-62. [DOI: 10.1016/s1074-5521(98)90056-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
68 Rieu P, Porteu F, Bessou G, Lesavre P, Halbwachs-Mecarelli L. Human neutrophils release their major membrane sialoprotein, leukosialin (CD43), during cell activation. Eur J Immunol 1992;22:3021-6. [PMID: 1358626 DOI: 10.1002/eji.1830221138] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 1.7] [Reference Citation Analysis]
69 Hara T, Kuriyama S, Kiyohara H, Nagase Y, Matsumoto M, Seya T. Soluble forms of membrane cofactor protein (CD46, MCP) are present in plasma, tears, and seminal fluid in normal subjects. Clin Exp Immunol 1992;89:490-4. [PMID: 1516264 DOI: 10.1111/j.1365-2249.1992.tb06986.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 1.5] [Reference Citation Analysis]
70 Jansen J, van der Poll T, Levi M, ten Cate H, Gallati H, ten Cate JW, van Deventer SJH. Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-α antibody. J Clin Immunol 1995;15:45-50. [DOI: 10.1007/bf01489489] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
71 Larregina A, Morelli A, Kolkowski E, Fainboim L. Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term culture. Immunology 1996;87:317-25. [PMID: 8698397 DOI: 10.1046/j.1365-2567.1996.451513.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 1.2] [Reference Citation Analysis]
72 Asmuth EJU, Leeuwenberg JFM, Linden CJ, Buurman WA. Tumour Necrosis Factor-alpha Induces Neutrophil-Mediated Injury of Cultured Human Endothelial Cells. Scand J Immunol 1991;34:197-206. [DOI: 10.1111/j.1365-3083.1991.tb01537.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
73 Modur V, Li Y, Zimmerman GA, Prescott SM, McIntyre TM. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest 1997;100:2752-6. [PMID: 9389739 DOI: 10.1172/JCI119821] [Cited by in Crossref: 139] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
74 Maymon E, Ghezzi F, Edwin SS, Mazor M, Yoon BH, Gomez R, Romero R. The tumor necrosis factor α and its soluble receptor profile in term and preterm parturition. American Journal of Obstetrics and Gynecology 1999;181:1142-8. [DOI: 10.1016/s0002-9378(99)70097-9] [Cited by in Crossref: 99] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
75 Roux-lombard P, Punzi L, Hasler F, Bas S, Todesco S, Gallati H, Guerne P, Dayer J. Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis & Rheumatism 1993;36:485-9. [DOI: 10.1002/art.1780360408] [Cited by in Crossref: 91] [Cited by in F6Publishing: 91] [Article Influence: 3.1] [Reference Citation Analysis]
76 Himmelfarb J, Le P, Klenzak J, Freedman S, Mcmenamin ME, Ikizler TA. Impaired monocyte cytokine production in critically ill patients with acute renal failure. Kidney International 2004;66:2354-60. [DOI: 10.1111/j.1523-1755.2004.66023.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
77 Sohda M, Misumi Y, Oda K. TNFα triggers release of extracellular vesicles containing TNFR1 and TRADD, which can modulate TNFα responses of the parental cells. Archives of Biochemistry and Biophysics 2015;587:31-7. [DOI: 10.1016/j.abb.2015.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
78 Shi M, Dennis K, Peschon JJ, Chandrasekaran R, Mikecz K. Antibody-induced shedding of CD44 from adherent cells is linked to the assembly of the cytoskeleton. J Immunol 2001;167:123-31. [PMID: 11418640 DOI: 10.4049/jimmunol.167.1.123] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
79 Staudinger T, Presterl E, Graninger W, Locker GJ, Knapp S, Laczika K, Klappacher G, Stoiser B, Wagner A, Tesinsky P, Kordova H, Frass M. Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock. Intensive Care Med 1996;22:888-93. [DOI: 10.1007/bf02044112] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
80 Kowanko IC, Ferrante A. Granulocyte-macrophage colony-stimulating factor augments neutrophil-mediated cartilage degradation and neutrophil adherence. Arthritis & Rheumatism 1991;34:1452-60. [DOI: 10.1002/art.1780341117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
81 Liabakk N, Sundan A, Waage A, Brockhaus M, Loetcher H, Lesslauer W, Espevik T. Development of immunoassays for the detection of soluble tumour necrosis factor receptors. Journal of Immunological Methods 1991;141:237-43. [DOI: 10.1016/0022-1759(91)90150-e] [Cited by in Crossref: 14] [Article Influence: 0.5] [Reference Citation Analysis]
82 Parsons PE, Matthay MA, Ware LB, Eisner MD; National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005;288:L426-31. [PMID: 15516488 DOI: 10.1152/ajplung.00302.2004] [Cited by in Crossref: 134] [Cited by in F6Publishing: 122] [Article Influence: 7.4] [Reference Citation Analysis]
83 Dri P, Gasparini C, Menegazzi R, Cramer R, Albéri L, Presani G, Garbisa S, Patriarca P. TNF-Induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase. J Immunol 2000;165:2165-72. [PMID: 10925303 DOI: 10.4049/jimmunol.165.4.2165] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 2.5] [Reference Citation Analysis]
84 Kimura F, Miyazaki M, Suwa T, Sugiura T, Shinoda T, Itoh H, Nagakawa K, Ambiru S, Shimizu H, Yoshitome H. Anti-inflammatory response in patients with obstructive jaundice caused by biliary malignancy. J Gastroenterol Hepatol. 2001;16:467-472. [PMID: 11354287 DOI: 10.1046/j.1440-1746.2001.02465.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
85 Foster PF, Kociss K, Shen J, Sankary HN, Mital D, Chong ASF, Xiao F, Williams JW. GRANULOCYTE COLONY-STIMULATING FACTOR IMMUNOMODULATION IN THE RAT CARDIAC TRANSPLANTATION MODEL: . Transplantation 1996;61:1122-5. [DOI: 10.1097/00007890-199604150-00026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
86 Aukrust P, Liabakk NB, Müller F, Espevik T, Frøland SS. Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation. Infection 1995;23:9-15. [PMID: 7744500 DOI: 10.1007/BF01710050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
87 Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR. Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol. 2012;36:261-270. [PMID: 22965073 DOI: 10.1159/000342333] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
88 Mueller SG, Schraw WP, Richmond A. Activation of Protein Kinase C Enhances the Phosphorylation of the Type B Interleukin-8 Receptor and Stimulates Its Degradation in Non-hematopoietic Cells. Journal of Biological Chemistry 1995;270:10439-48. [DOI: 10.1074/jbc.270.18.10439] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
89 Kahn J, Ingraham RH, Shirley F, Migaki GI, Kishimoto TK. Membrane proximal cleavage of L-selectin: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin. J Cell Biol 1994;125:461-70. [PMID: 7512970 DOI: 10.1083/jcb.125.2.461] [Cited by in Crossref: 147] [Cited by in F6Publishing: 149] [Article Influence: 5.3] [Reference Citation Analysis]
90 Martinet N, Charles T, Vaillant P, Vignaud J, Lambert J, Martinet Y. Characterization of a Tumor Necrosis Factor- α Inhibitor Activity in Cancer Patients. Am J Respir Cell Mol Biol 1992;6:510-5. [DOI: 10.1165/ajrcmb/6.5.510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
91 Lin MT, Saito H, Fukushima R, Inaba T, Fukatsu K, Inoue T, Furukawa S, Han I, Muto T. Route of nutritional supply influences local, systemic, and remote organ responses to intraperitoneal bacterial challenge. Ann Surg 1996;223:84-93. [PMID: 8554423 DOI: 10.1097/00000658-199601000-00012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 3.0] [Reference Citation Analysis]
92 Xavier CV, da S Setúbal S, Lacouth-Silva F, Pontes AS, Nery NM, de Castro OB, Fernandes CFC, Soares AM, Fortes-Dias CL, Zuliani JP. Phospholipase A2 Inhibitor from Crotalus durissus terrificus rattlesnake: Effects on human peripheral blood mononuclear cells and human neutrophils cells. Int J Biol Macromol 2017;105:1117-25. [PMID: 28743568 DOI: 10.1016/j.ijbiomac.2017.07.140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
93 Tchorzewski H, Zeman K, Kantorski J, Paleolog E, Kahan M, Feldmann M, Kwinkowski M, Guga P, Szymanska B, Parniewski P, Wilk A, Jarosz J. The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro. Mediators Inflamm 1993;2:41-8. [PMID: 18475501 DOI: 10.1155/S0962935193000055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Tripathi RC, Yang C, Tripathi BJ, Borisuth NSC. Role of receptors in the trabecular meshwork of the eye as targeted to the development of antiglaucoma therapy. Drug Dev Res 1992;27:191-228. [DOI: 10.1002/ddr.430270302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
95 Malejczyk M, Jóźwiak J, Osiecka A, Roszkowski PI, Mazurkiewicz-Smoktunowicz W, Rogoziński TT, Walczak L, Jabłońska S, Majewski S, Malejczyk J. Serum levels of soluble tumor-necrosis-factor receptors in patients with benign and malignant HPV-associated anogenital lesions. Int J Cancer 1997;73:16-9. [PMID: 9334803 DOI: 10.1002/(sici)1097-0215(19970926)73:1<16::aid-ijc3>3.0.co;2-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
96 Kowanko IC, Ferrante A, Clemente G, Youssef PP, Smith M. Tumor necrosis factor priming of peripheral blood neutrophils from rheumatoid arthritis patients. J Clin Immunol 1996;16:216-21. [DOI: 10.1007/bf01541227] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
97 Ellis M, Hedstrom U, Frampton C, Alizadeh H, Kristensen J, Shammas FV, al-Ramadi BK. Modulation of the systemic inflammatory response by recombinant human interleukin-11: a prospective randomized placebo controlled clinical study in patients with hematological malignancy. Clin Immunol 2006;120:129-37. [PMID: 16644288 DOI: 10.1016/j.clim.2006.03.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
98 Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA. 1992;89:4845-4849. [PMID: 1317575 DOI: 10.1073/pnas.89.11.4845] [Cited by in Crossref: 534] [Cited by in F6Publishing: 511] [Article Influence: 17.8] [Reference Citation Analysis]
99 Gaede KI, Fitschen J, Ernst M, Martinet N, Schlaak M, Müller-quernheim J. EXPRESSION OF TUMOUR NECROSIS FACTOR RECEPTORS (CD120a AND CD120b) ON BRONCHOALVEOLAR CELLS. Cytokine 1999;11:611-6. [DOI: 10.1006/cyto.1998.0469] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
100 Aderka D, Wysenbeek A, Engelmann H, Cope AP, Brennan F, Molad Y, Hornik V, Levo Y, Maini RN, Feldmann M, Wallach D. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis & Rheumatism 1993;36:1111-20. [DOI: 10.1002/art.1780360812] [Cited by in Crossref: 122] [Cited by in F6Publishing: 116] [Article Influence: 4.2] [Reference Citation Analysis]
101 Rogy MA, Oldenburg HSA, Calvano SE, Montegut WJ, Stackpole SA, van Zee KJ, Marra MN, Scott RW, Seilhammer JJ, Moldawer LL, Lowry SF. The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock. J Clin Immunol 1994;14:120-33. [DOI: 10.1007/bf01541345] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
102 Haas SL, Lohse P, Schmitt WH, Hildenbrand R, Karaorman M, Singer MV, Böcker U. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution. Gastroenterology 2006;130:172-8. [PMID: 16401480 DOI: 10.1053/j.gastro.2005.09.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
103 Fotin-mleczek M, Welte S, Mader O, Duchardt F, Fischer R, Hufnagel H, Scheurich P, Brock R. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. Journal of Cell Science 2005;118:3339-51. [DOI: 10.1242/jcs.02460] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 4.6] [Reference Citation Analysis]
104 Dong ZM, Murphy JW. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J Clin Invest 1996;97:689-98. [PMID: 8609224 DOI: 10.1172/JCI118466] [Cited by in Crossref: 82] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
105 Ware CF, VanArsdale TL, Crowe PD, Browning JL. The ligands and receptors of the lymphotoxin system. Curr Top Microbiol Immunol 1995;198:175-218. [PMID: 7774281 DOI: 10.1007/978-3-642-79414-8_11] [Cited by in Crossref: 59] [Cited by in F6Publishing: 94] [Article Influence: 2.2] [Reference Citation Analysis]
106 Shibata M, Nezu T, Kanou H, Nagata Y, Kimura T, Takekawa M, Ando K, Fukuzawa M. Immunomodulatory Effects of Low Dose cis -Diaminedichloroplatinum (Cisplatin) Combined with UFT and PSK in Patients with Advanced Colorectal Cancer. Cancer Investigation 2002;20:166-73. [DOI: 10.1081/cnv-120001142] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
107 Andus T, Gross V, Holstege A, Ott M, Weber M, David M, Gallati H, Gerok W, Schölmerich J. High concentrations of soluble tumor necrosis factor receptors in ascites. Hepatology. 1992;16:749-755. [PMID: 1324217 DOI: 10.1002/hep.1840160322] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
108 Al-Shamkhani A, Mallett S, Brown MH, James W, Barclay AN. Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells. J Biol Chem 1997;272:5275-82. [PMID: 9030600 DOI: 10.1074/jbc.272.8.5275] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
109 Porteu F, Hieblot C. Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. Journal of Biological Chemistry 1994;269:2834-40. [DOI: 10.1016/s0021-9258(17)42018-7] [Cited by in Crossref: 46] [Article Influence: 1.6] [Reference Citation Analysis]
110 Joyce DA, Steer JH. Tumor Necrosis Factor α and Interleukin-1α Stimulate Late Shedding of p75 TNF Receptors but Not p55 TNF Receptors from Human Monocytes. Journal of Interferon & Cytokine Research 1995;15:947-54. [DOI: 10.1089/jir.1995.15.947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
111 Vendrame E, Martínez-Maza O. Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma. J Proteome Res 2011;10:113-9. [PMID: 20886858 DOI: 10.1021/pr100729z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
112 Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, Brennan FM, Maini RN, Wallach D, Feldmann M. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992;35:1160-9. [PMID: 1329774 DOI: 10.1002/art.1780351008] [Cited by in Crossref: 227] [Cited by in F6Publishing: 221] [Article Influence: 7.6] [Reference Citation Analysis]
113 Poppers DM, Schwenger P, Vilček J. Persistent Tumor Necrosis Factor Signaling in Normal Human Fibroblasts Prevents the Complete Resynthesis of IκB-α. Journal of Biological Chemistry 2000;275:29587-93. [DOI: 10.1074/jbc.m002806200] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
114 Jiménez-gallo D, de la Varga-martínez R, Ossorio-garcía L, Collantes-rodríguez C, Rodríguez C, Linares-barrios M. Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa. Cytokine 2018;103:20-4. [DOI: 10.1016/j.cyto.2017.12.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
115 Grabellus F, Podleska LE, Bjerlestam S, Sheu S, Lendemans S, Schmid KW, Taeger G. Increased shedding of soluble TNF-receptor 1 during hyperthermic TNF-α-based isolated limb perfusion. International Journal of Hyperthermia 2010;27:33-41. [DOI: 10.3109/02656736.2010.508067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
116 van Kooten C, Gaillard C, Galizzi JP, Hermann P, Fossiez F, Banchereau J, Blanchard D. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol 1994;24:787-92. [PMID: 7512028 DOI: 10.1002/eji.1830240402] [Cited by in Crossref: 103] [Cited by in F6Publishing: 106] [Article Influence: 3.7] [Reference Citation Analysis]
117 Shibata M, Takekawa M, Amano S. Increased serum concentrations of soluble tumor necrosis factor receptor I in noncachectic and cachectic patients with advanced gastric and colorectal cancer. Surg Today 1998;28:884-8. [DOI: 10.1007/s005950050247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
118 Heilig B, Wermann M, Gallati H, Brockhaus M, Berke B, Egen O, Pezzutto A, Hunstein W. Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin Investig 1992;70:22-7. [DOI: 10.1007/bf00422933] [Cited by in Crossref: 42] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
119 Tilg H, Trehu E, Shapiro L, Pape D, Atkins MB, Dinarello CA, Mier JW. Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1α infusion in humans. Cytokine 1994;6:215-9. [DOI: 10.1016/1043-4666(94)90044-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
120 Burkhardt O, Merker H. Immunoelectron microscopic investigations of patching, capping, endocytotic and shedding processes in T and B lymphocytes. Annals of Anatomy - Anatomischer Anzeiger 2002;184:45-53. [DOI: 10.1016/s0940-9602(02)80034-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
121 Biró A, Hérincs Z, Fellinger E, Szilágyi L, Barad Z, Gergely J, Gráf L, Sármay G. Characterization of a trypsin-like serine protease of activated B cells mediating the cleavage of surface proteins. Biochim Biophys Acta 2003;1624:60-9. [PMID: 14642814 DOI: 10.1016/j.bbagen.2003.09.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
122 Chheda S, Palkowetz KH, Garofalo R, Rassin DK, Goldman AS. Decreased Interleukin-10 Production by Neonatal Monocytes and T Cells: Relationship to Decreased Production and Expression of Tumor Necrosis Factor-α and Its Receptors. Pediatr Res 1996;40:475-83. [DOI: 10.1203/00006450-199609000-00018] [Cited by in Crossref: 86] [Cited by in F6Publishing: 67] [Article Influence: 3.3] [Reference Citation Analysis]
123 Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA. 2005;102:3372-3377. [PMID: 15728381 DOI: 10.1073/pnas.0408506102] [Cited by in Crossref: 354] [Cited by in F6Publishing: 328] [Article Influence: 20.8] [Reference Citation Analysis]
124 Derouich-Guergour D, Brenier-Pinchart MP, Ambroise-Thomas P, Pelloux H. Tumour necrosis factor alpha receptors: role in the physiopathology of protozoan parasite infections. Int J Parasitol 2001;31:763-9. [PMID: 11403766 DOI: 10.1016/s0020-7519(01)00194-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
125 Gatanaga T, Hwang C, Gatanaga M, Cappuccini F, Yamamoto RS, Granger GA. The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro. Cellular Immunology 1991;138:1-10. [DOI: 10.1016/0008-8749(91)90127-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
126 Kishimoto TK, Kahn J, Migaki G, Mainolfi E, Shirley F, Ingraham R, Rothlein R. Regulation of L-selectin expression by membrane proximal proteolysis. Agents Actions Suppl 1995;47:121-34. [PMID: 7540352 DOI: 10.1007/978-3-0348-7343-7_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
127 Girón-González JA, Martínez-Sierra C, Rodriguez-Ramos C, Macías MA, Rendón P, Díaz F, Fernández-Gutiérrez C, Martín-Herrera L. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int. 2004;24:437-445. [PMID: 15482340 DOI: 10.1111/j.1478-3231.2004.0951.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 3.7] [Reference Citation Analysis]
128 Lopez S, Halbwachs-Mecarelli L, Ravaud P, Bessou G, Dougados M, Porteu F. Neutrophil expression of tumour necrosis factor receptors (TNF-R) and of activation markers (CD11b, CD43, CD63) in rheumatoid arthritis. Clin Exp Immunol 1995;101:25-32. [PMID: 7621589 DOI: 10.1111/j.1365-2249.1995.tb02272.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
129 Greenfield EM, Bi Y, Miyauchi A. Regulation of osteoclast activity. Life Sciences 1999;65:1087-102. [DOI: 10.1016/s0024-3205(99)00156-3] [Cited by in Crossref: 75] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
130 Bereta J, Bereta M, Cohen S, Cohen MC. Studies on the role of protein kinases in the TNF-mediated enhancement of murine tumor cell-endothelial cell interactions. J Cell Biochem 1991;47:62-78. [DOI: 10.1002/jcb.240470109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
131 Pollmächer T, Hinze-Selch D, Mullington J. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol 1996;16:403-9. [PMID: 8889915 DOI: 10.1097/00004714-199610000-00011] [Cited by in Crossref: 152] [Cited by in F6Publishing: 140] [Article Influence: 6.1] [Reference Citation Analysis]
132 Brockhaus M, Bar-khayim Y, Gurwicz S, Frensdorff A, Haran N. Plasma tumor necrosis factor soluble receptors in chronic renal failure. Kidney International 1992;42:663-7. [DOI: 10.1038/ki.1992.332] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 2.2] [Reference Citation Analysis]
133 Turner MD, Chaudhry A, Nedjai B. Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion. Biosci Rep 2012;32:105-12. [PMID: 22115362 DOI: 10.1042/BSR20110089] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
134 Deaciuc IV, D'souza NB, Bagby GJ, Lang CH, Spitzer JJ. Effect of Acute Alcohol Administration on TNF-alpha Binding to Neutrophils and Isolated Liver Plasma Membranes. Alcoholism Clin Exp Res 1992;16:533-8. [DOI: 10.1111/j.1530-0277.1992.tb01412.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
135 Clodi K, Younes A. Reed-Sternberg Cells and the TNF Family of Receptors/Ligands. Leukemia & Lymphoma 2009;27:195-204. [DOI: 10.3109/10428199709059676] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
136 Jagels MA, Travis J, Potempa J, Pike R, Hugli TE. Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect Immun 1996;64:1984-91. [PMID: 8675297 DOI: 10.1128/iai.64.6.1984-1991.1996] [Cited by in Crossref: 86] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
137 Cox FA, Stiller-winkler R, Hadnagy W, Ranft U, Idel H. Soluble tumor necrosis factor receptor (sTNF RII) in sera of children and traffic-derived particulate air pollution. Zentralblatt für Hygiene und Umweltmedizin 1999;202:489-500. [DOI: 10.1016/s0934-8859(99)80038-8] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
138 Feehan C, Darlak K, Kahn J, Walcheck B, Spatola AF, Kishimoto TK. Shedding of the Lymphocyte L-Selectin Adhesion Molecule Is Inhibited by a Hydroxamic Acid-based Protease Inhibitor. Journal of Biological Chemistry 1996;271:7019-24. [DOI: 10.1074/jbc.271.12.7019] [Cited by in Crossref: 114] [Cited by in F6Publishing: 114] [Article Influence: 4.4] [Reference Citation Analysis]
139 Vulcano M, Alves Rosa MF, Minnucci FS, Cherñavsky AC, Isturiz MA. N-formyl-methionyl-leucyl-phenylalanine (fMLP) inhibits tumour necrosis factor-alpha (TNF-alpha) production on lipopolysaccharide (LPS)-stimulated human neutrophils. Clin Exp Immunol 1998;113:39-47. [PMID: 9697981 DOI: 10.1046/j.1365-2249.1998.00631.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
140 Hino T, Nakamura H, Abe S, Saito H, Inage M, Terashita K, Kato S, Tomoike H. Hydrogen Peroxide Enhances Shedding of Type I Soluble Tumor Necrosis Factor Receptor from Pulmonary Epithelial Cells. Am J Respir Cell Mol Biol 1999;20:122-8. [DOI: 10.1165/ajrcmb.20.1.3217] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
141 Fissolo N, Cantó E, Vidal-Jordana A, Castilló J, Montalban X, Comabella M. Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis. J Neuroimmunol 2014;271:56-9. [PMID: 24794503 DOI: 10.1016/j.jneuroim.2014.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
142 Bazil V, Strominger JL. CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes. Proc Natl Acad Sci U S A 1993;90:3792-6. [PMID: 7683406 DOI: 10.1073/pnas.90.9.3792] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 1.9] [Reference Citation Analysis]
143 Austgulen R, Lien E, Liabakk N, Jacobsen G, Arntzen KJ. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 1994;57:149-55. [DOI: 10.1016/0028-2243(94)90291-7] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 2.5] [Reference Citation Analysis]
144 Lentz MR. The role of therapeutic apheresis in the treatment of cancer: a review. Ther Apher 1999;3:40-9. [PMID: 10079805 DOI: 10.1046/j.1526-0968.1999.00147.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
145 Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992;90:533-6. [PMID: 1322942 DOI: 10.1172/JCI115891] [Cited by in Crossref: 157] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
146 Yamashita K, Takahashi A, Kobayashi S, Hirata H, Mesner PW, Kaufmann SH, Yonehara S, Yamamoto K, Uchiyama T, Sasada M. Caspases Mediate Tumor Necrosis Factor-–Induced Neutrophil Apoptosis and Downregulation of Reactive Oxygen Production. Blood 1999;93:674-85. [DOI: 10.1182/blood.v93.2.674.402k26_674_685] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
147 Moghaddami N, Costabile M, Grover PK, Jersmann HP, Huang ZH, Hii CS, Ferrante A. Unique effect of arachidonic acid on human neutrophil TNF receptor expression: up-regulation involving protein kinase C, extracellular signal-regulated kinase, and phospholipase A2. J Immunol 2003;171:2616-24. [PMID: 12928414 DOI: 10.4049/jimmunol.171.5.2616] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
148 Read SB, Kulprathipanja NV, Gomez GG, Paul DB, Winston KR, Robbins JM, Kruse CA. Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification. J Interferon Cytokine Res 2003;23:379-93. [PMID: 14511464 DOI: 10.1089/107999003322226032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
149 D'osualdo A, Ferlito F, Prigione I, Obici L, Meini A, Zulian F, Pontillo A, Corona F, Barcellona R, Duca MD, Santamaria G, Traverso F, Picco P, Baldi M, Plebani A, Ravazzolo R, Ceccherini I, Martini A, Gattorno M. Neutrophils from patients withTNFRSF1A mutations display resistance to tumor necrosis factor–induced apoptosis: Pathogenetic and clinical implications. Arthritis Rheum 2006;54:998-1008. [DOI: 10.1002/art.21657] [Cited by in Crossref: 104] [Cited by in F6Publishing: 81] [Article Influence: 6.5] [Reference Citation Analysis]
150 Kanaoka Y, Yagi T, Sadamori H, Matsukawa H, Matsuda H, Inagaki M, Ishikawa T, Saito S, Iwagaki H, Tanaka N. Analysis of Host Response to Hepatectomy by Simultaneous Measurement of Cytokines in the Portal Vein, Caval Vein and Radial Artery. J Int Med Res 2002;30:496-505. [DOI: 10.1177/147323000203000505] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
151 Mantovani A, Locati M, Allavena P, Sozzani S. The Chemokine Superfamily: Crosstalk with the IL-1 System. Immunobiology 1996;195:522-49. [DOI: 10.1016/s0171-2985(96)80020-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
152 Martino G, Consiglio A, Franciotta DM, Corti A, Filippi M, Vandenbroeck K, Sciacca FL, Comi G, M.e. Grimaldi L. Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis. Journal of the Neurological Sciences 1997;152:51-61. [DOI: 10.1016/s0022-510x(97)00142-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
153 Márquez M, Fernández-Gutiérrez C, Montes-de-Oca M, Blanco MJ, Brun F, Rodríguez-Ramos C, Girón-González JA. Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis. Clin Exp Immunol. 2009;158:219-229. [PMID: 19737142 DOI: 10.1111/j.1365-2249.2009.04005.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
154 Edwards CK, Borcherding SM, Zhang J, Borcherding DR. Role of Tumor Necrosis Factor α in Acute and Chronic Inflammatory Responses: Novel Therapeutic Approaches. Xenobiotics and Inflammation. Elsevier; 1994. pp. 97-147. [DOI: 10.1016/b978-0-12-628930-5.50010-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
155 Hill CM, Lunec J. The TNF-ligand and receptor superfamilies: controllers of immunity and the Trojan horses of autoimmune disease? Mol Aspects Med 1996;17:455-509. [PMID: 9013494 DOI: 10.1016/s0098-2997(96)00011-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
156 Sidhu RS, Bollon AP. Tumor necrosis factor activities and cancer therapy--a perspective. Pharmacol Ther 1993;57:79-128. [PMID: 8390056 DOI: 10.1016/0163-7258(93)90037-e] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
157 Beyaert R, Van Loo G, Heyninck K, Vandenabeele P. Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. Int Rev Cytol 2002;214:225-72. [PMID: 11893167 DOI: 10.1016/s0074-7696(02)14007-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
158 Balkwill FR. Tumour necrosis factor and cancer. Prog Growth Factor Res 1992;4:121-37. [PMID: 1338573 DOI: 10.1016/0955-2235(92)90027-f] [Cited by in Crossref: 34] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
159 Heilig B, Fiehn C, Brockhaus M, Gallati H, Pezzutto A, Hunstein W. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol 1993;13:321-8. [DOI: 10.1007/bf00920240] [Cited by in Crossref: 38] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
160 Murphy J, Wu-hsieh B, Singer-vermes L, Ferrante A, Moser S, Russo M, Vaz C, Burger E, Calich V, Kowanko I, Rathjen D, Martin A, Bucy R, Chen Q. Cytokines in the host response to mycotic agents. Med Mycol 1994;32:203-10. [DOI: 10.1080/02681219480000831] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
161 Shimamura H, Iwagaki H, Gouchi A, Morimoto Y, Ariki N, Funaki M, Tanaka N. Autologous Serum Deprivation Restored IL-1 Receptor Antagonist Production by Peripheral Blood Mononuclear Cells in Patients with Gastric Cancer. J Int Med Res 2000;28:277-87. [DOI: 10.1177/147323000002800604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
162 Christman JW, Holden EP, Blackwell TS. Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med. 1995;23:955-963. [PMID: 7736757 DOI: 10.1097/00003246-199505000-00027] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 2.4] [Reference Citation Analysis]
163 Kilpatrick LE, Song YH, Rossi MW, Korchak HM. Serine phosphorylation of p60 tumor necrosis factor receptor by PKC-delta in TNF-alpha-activated neutrophils. Am J Physiol Cell Physiol 2000;279:C2011-8. [PMID: 11078718 DOI: 10.1152/ajpcell.2000.279.6.C2011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
164 Vazifeh D, Bryskier A, Labro MT. Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils. Antimicrob Agents Chemother 2000;44:511-21. [PMID: 10681311 DOI: 10.1128/AAC.44.3.511-521.2000] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
165 Bjornberg F, Lantz M, Gullberg U. Metalloproteases and Serineproteases are Involved in the Cleavage of the Two Tumour Necrosis Factor (TNF) Receptors to Soluble Forms in the Myeloid Cell Lines U-937 and THP-1. Scand J Immunol 1995;42:418-24. [DOI: 10.1111/j.1365-3083.1995.tb03675.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
166 Comabella M, Julià E, Tintoré M, Brieva L, Téllez N, Río J, López C, Rovira A, Montalban X. Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis. J Neurol 2008;255:1136-41. [DOI: 10.1007/s00415-008-0855-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
167 Zhang L, Higuchi M, Totpal K, Chaturvedi M, Aggarwal B. Staurosporine induces the cell surface expression of both forms of human tumor necrosis factor receptors on myeloid and epithelial cells and modulates ligand-induced cellular response. Journal of Biological Chemistry 1994;269:10270-9. [DOI: 10.1016/s0021-9258(17)34057-7] [Cited by in Crossref: 12] [Article Influence: 0.4] [Reference Citation Analysis]
168 Grazioli L, Casero D, Restivo A, Cozzi E, Marcucci F. Tumor necrosis factor-driven formation of disulfide-linked receptor aggregates. Journal of Biological Chemistry 1994;269:22304-9. [DOI: 10.1016/s0021-9258(17)31790-8] [Cited by in Crossref: 9] [Article Influence: 0.3] [Reference Citation Analysis]
169 Moghaddami N, Irvine J, Gao X, Grover PK, Costabile M, Hii CS, Ferrante A. Novel action of n-3 polyunsaturated fatty acids: inhibition of arachidonic acid-induced increase in tumor necrosis factor receptor expression on neutrophils and a role for proteases. Arthritis Rheum 2007;56:799-808. [PMID: 17328054 DOI: 10.1002/art.22432] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
170 Vernooy JH, Küçükaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, Wouters EF. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002;166:1218-24. [PMID: 12403691 DOI: 10.1164/rccm.2202023] [Cited by in Crossref: 210] [Cited by in F6Publishing: 213] [Article Influence: 10.5] [Reference Citation Analysis]
171 Farese AM, Cohen MV, Macvittie TJ. Recombinant Human G-CSF Enhances Recovery and Improves Survival from Severe Radiation-Induced Myelosuppression. In: Molineux G, Foote M, Arvedson T, editors. Twenty Years of G-CSF. Basel: Springer; 2012. pp. 365-80. [DOI: 10.1007/978-3-0348-0218-5_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
172 Yang WS, Kim HW, Lee JM, Han NJ, Lee MJ, Park S. 1,25-Dihydroxyvitamin D 3 Causes ADAM10-Dependent Ectodomain Shedding of Tumor Necrosis Factor Receptor 1 in Vascular Smooth Muscle Cells. Mol Pharmacol 2015;87:533-42. [DOI: 10.1124/mol.114.097147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
173 Zangerle R, Gallati H, Sarcletti M, Wachter H, Fuchs D. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection. Immunol Lett 1994;41:229-34. [PMID: 8002043 DOI: 10.1016/0165-2478(94)90138-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 1.4] [Reference Citation Analysis]
174 Xanthoulea S, Pasparakis M, Kousteni S, Brakebusch C, Wallach D, Bauer J, Lassmann H, Kollias G. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases. J Exp Med 2004;200:367-76. [PMID: 15289505 DOI: 10.1084/jem.20040435] [Cited by in Crossref: 127] [Cited by in F6Publishing: 123] [Article Influence: 7.1] [Reference Citation Analysis]
175 Cowburn AS, Sobolewski A, Reed BJ, Deighton J, Murray J, Cadwallader KA, Bradley JR, Chilvers ER. Aminopeptidase N (CD13) Regulates Tumor Necrosis Factor-α-induced Apoptosis in Human Neutrophils. Journal of Biological Chemistry 2006;281:12458-67. [DOI: 10.1074/jbc.m511277200] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
176 D. Heresbach, J.-p. Letourneur, I.. Value of Early Blood Th-1 Cytokine Determination in Predicting Severity of Acute Pancreatitis. Scandinavian Journal of Gastroenterology 2009;33:554-60. [DOI: 10.1080/00365529850172160] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
177 Hohmann HP, Remy R, Aigner L, Brockhaus M, van Loon AP. Protein kinases negatively affect nuclear factor-kappa B activation by tumor necrosis factor-alpha at two different stages in promyelocytic HL60 cells. Journal of Biological Chemistry 1992;267:2065-72. [DOI: 10.1016/s0021-9258(18)46053-x] [Cited by in Crossref: 21] [Article Influence: 0.7] [Reference Citation Analysis]
178 Fahmi H, Chaby R. Differential Recovery of Macrophages from Endotoxin-Tolerant States Elicited by Lipopolysaccharide and Enzymatic Treatments. Immunological Investigations 2009;23:243-58. [DOI: 10.3109/08820139409066821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
179 Hiraishi K, Takeda Y, Shiobara N, Shibusawa H, Jimma F, Kashiwagi N, Saniabadi AR, Adachi M. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial. 2003;7:334-340. [PMID: 12924609 DOI: 10.1046/j.1526-0968.2003.00049.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 4.9] [Reference Citation Analysis]
180 Coyne C, Howell T, Smodlaka H, Willetto C, Fenwick BW, Chenney E. Alterations in membrane-associated CD14 expression and the simultaneous liberation of soluble CD14 fragment in adherent macrophages mediated by a leukocyte carboxyl/aspartate protease. Journal of Endotoxin Research 2002;8:273-83. [DOI: 10.1177/09680519020080040401] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
181 Gea J, Barreiro E, Orozco-levi M. Systemic Inflammation in COPD. Clinical Pulmonary Medicine 2009;16:233-42. [DOI: 10.1097/cpm.0b013e3181bc3bb7] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
182 Ayroldi E, Cannarile L, Ricardi C. Modulation of superantigen-induced T-cell deletion by antibody anti-Pgp-1 (CD44). Immunology 1996;87:191-7. [PMID: 8698379 DOI: 10.1046/j.1365-2567.1996.466540.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
183 Schleiffenbaum B, Spertini O, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992;119:229-38. [PMID: 1382078 DOI: 10.1083/jcb.119.1.229] [Cited by in Crossref: 286] [Cited by in F6Publishing: 279] [Article Influence: 9.5] [Reference Citation Analysis]
184 Leon LR, Dineen S, Blaha MD, Rodriguez-fernandez M, Clarke DC. Attenuated thermoregulatory, metabolic, and liver acute phase protein response to heat stroke in TNF receptor knockout mice. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2013;305:R1421-32. [DOI: 10.1152/ajpregu.00127.2013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
185 Jungi TW, Nydegger UE. Proposed mechanisms of action of intravenous IgG (IVIG) in autoimmune diseases. Transfusion Science 1992;13:267-90. [DOI: 10.1016/0955-3886(92)90138-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
186 Ogle JD, Noel JG, Sramkoski RM, Ogle CK, Alexander JW. Effects of combination of tumor necrosis factor alpha and chemotactic peptide, f-Met-Leu-Phe, on phagocytosis of opsonized microspheres by human neutrophils. Inflammation 1992;16:57-68. [PMID: 1544681 DOI: 10.1007/BF00917515] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
187 Biasi D, Bambara LM, Carletto A, Caraffi M, Serra MC, Chirumbolo S, Bellavite P. Factor-specific changes in oxidative burst response of human neutrophils in skin-window exudates. Inflammation 1993;17:13-23. [DOI: 10.1007/bf00916388] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
188 Rock CS, Lowry SF. Tumor necrosis factor-α. Journal of Surgical Research 1991;51:434-45. [DOI: 10.1016/0022-4804(91)90146-d] [Cited by in Crossref: 44] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
189 Ward R, McLeish KR. Soluble TNF alpha receptors are increased in chronic renal insufficiency and hemodialysis and inhibit neutrophil priming by TNF alpha. Artif Organs 1996;20:390-5. [PMID: 8725616 DOI: 10.1111/j.1525-1594.1996.tb04521.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
190 Motamed-Gorji N, Matin N, Tabatabaie O, Pavone P, Romano C, Falsaperla R, Vitaliti G. Biological Drugs in Guillain-Barré Syndrome: An Update. Curr Neuropharmacol 2017;15:938-50. [PMID: 27964705 DOI: 10.2174/1570159X14666161213114904] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
191 Kimura F, Miyazaki M, Suwa T, Sugiura T, Shinoda T, Itoh H, Ambiru S, Shimizu H, Nakagawa K. Plasma concentration of cytokine antagonists in patients with infection following liver resection. Br J Surg 1998;85:1631-5. [PMID: 9876064 DOI: 10.1046/j.1365-2168.1998.00949.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
192 Alexander HR, Doherty GM, Block MI, Kragel PJ, Jensen JC, Langstein HN, Walker E, Norton JA. Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats. Infect Immun 1991;59:3889-94. [PMID: 1937748 DOI: 10.1128/iai.59.11.3889-3894.1991] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
193 Spahr L, Giostra E, Frossard JL, Bresson-Hadni S, Rubbia-Brandt L, Hadengue A. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J Hepatol. 2004;41:229-234. [PMID: 15288471 DOI: 10.1016/j.jhep.2004.04.028] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
194 Brennan FM, Gibbons DL, Cope AP, Katsikis P, Maini RN, Feldmann M. TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action. Scand J Immunol 1995;42:158-65. [PMID: 7631138 DOI: 10.1111/j.1365-3083.1995.tb03639.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.2] [Reference Citation Analysis]
195 Xing L, Remick DG. Neutrophils as firemen, production of anti-inflammatory mediators by neutrophils in a mixed cell environment. Cell Immunol 2004;231:126-32. [PMID: 15919377 DOI: 10.1016/j.cellimm.2004.12.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
196 Ajello F, La Licata R, Lodato M, Vitale F, Bonura F, Valenti R, Bruno M, Romano N. Soluble tumor necrosis factor alpha receptors (sTNF-Rs) in HIV-1-infected intravenous drug users: change in circulating sTNF-R type II level and survival for AIDS patients. Eur J Epidemiol 2000;16:209-16. [PMID: 10870934 DOI: 10.1023/a:1007632617516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
197 Rodriguez-Ramos C, Galan F, Diaz F, Elvira J, Martin-Herrera L, Giron-Gonzalez JA. Expression of proinflammatory cytokines and gheir inhibitors during the course of spontaneous bacterial peritonitis. Dig Dis Sci. 2001;46:1668-1676. [PMID: 11508666 DOI: 10.1023/a:1010645302750] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
198 Pandiella A, Massagué J. Multiple signals activate cleavage of the membrane transforming growth factor-alpha precursor. Journal of Biological Chemistry 1991;266:5769-73. [DOI: 10.1016/s0021-9258(19)67662-3] [Cited by in Crossref: 71] [Article Influence: 2.3] [Reference Citation Analysis]
199 Laske C, Oschmann P, Tofighi J, Kuehne SB, Diehl H, Bregenzer T, Kraus J, Bauer R, Chatzimanolis N, Kern A, Traupe H, Kaps M. Induction of sTNF-R1 and sTNF-R2 by interferon beta-1b in correlation with clinical and MRI activity: Soluble TNF-receptors in multiple sclerosis. Acta Neurologica Scandinavica 2001;103:105-13. [DOI: 10.1034/j.1600-0404.2001.103002105.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
200 Ceconi C, Curello S, Bachetti T, Corti A, Ferrari R. Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? Prog Cardiovasc Dis 1998;41:25-30. [PMID: 9715820 DOI: 10.1016/s0033-0620(98)80028-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
201 Balteskard L, Unneberg K, Halvorsen D, Ytrebø LM, Waage A, Sjursen H, Revhaug A. The Influence of Growth Hormone on Tumour Necrosis Factor and Neutrophil Leukocyte Function in Sepsis. Scandinavian Journal of Infectious Diseases 2009;29:393-9. [DOI: 10.3109/00365549709011837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
202 Schr�der J-. Peptides and cytokines. Arch Dermatol Res 1992;284:S22-6. [DOI: 10.1007/bf00638236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
203 Harrington JF, Messier AA, Levine A, Szmydynger-chodobska J, Chodobski A. Shedding of Tumor Necrosis Factor Type 1 Receptor after Experimental Spinal Cord Injury. Journal of Neurotrauma 2005;22:919-28. [DOI: 10.1089/neu.2005.22.919] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
204 Meliconi R, Uguccioni M, Lalli E, Nesci S, Delfini C, Paradisi O, Lucarelli G, Gasbarrini G, Facchini A. Increased serum concentrations of tumour necrosis factor in beta thalassaemia: effect of bone marrow transplantation. J Clin Pathol 1992;45:61-5. [PMID: 1740519 DOI: 10.1136/jcp.45.1.61] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
205 Chin YR, Horwitz MS. Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex. J Virol 2005;79:13606-17. [PMID: 16227281 DOI: 10.1128/JVI.79.21.13606-13617.2005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
206 Spoettl T, Hausmann M, Klebl F, Dirmeier A, Klump B, Hoffmann J, Herfarth H, Timmer A, Rogler G. Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients. Inflamm Bowel Dis. 2007;13:727-732. [PMID: 17260368 DOI: 10.1002/ibd.20107] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
207 Hall RI, Smith MS, Rocker G. The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations. Anesthesia & Analgesia 1997;85:766-82. [DOI: 10.1213/00000539-199710000-00011] [Cited by in Crossref: 230] [Cited by in F6Publishing: 166] [Article Influence: 9.2] [Reference Citation Analysis]
208 Ramon-Luing LA, Ocaña-Guzman R, Téllez-Navarrete NA, Preciado-García M, Romero-Rodríguez DP, Espinosa E, Reyes-Terán G, Chavez-Galan L. High Levels of TNF-α and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection. Life (Basel) 2021;11:527. [PMID: 34198803 DOI: 10.3390/life11060527] [Reference Citation Analysis]
209 Grassi-oliveira R, Brietzke E, Pezzi JC, Lopes RP, Teixeira AL, Bauer ME. Increased soluble tumor necrosis factor-α receptors in patients with major depressive disorder: Soluble TNF-α receptors in major depression. Psychiatry and Clinical Neurosciences 2009;63:202-8. [DOI: 10.1111/j.1440-1819.2008.01918.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
210 Remick DG, Garg SJ, Newcomb DE, Wollenberg G, Huie TK, Bolgos GL. Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. Crit Care Med 1998;26:895-904. [PMID: 9590320 DOI: 10.1097/00003246-199805000-00025] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 3.1] [Reference Citation Analysis]
211 Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, Tripathi G, Ashour E, Abdalla MS, Sharada HM. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond). 2010;7:15. [PMID: 20353583 DOI: 10.1186/1476-9255-7-15] [Cited by in Crossref: 220] [Cited by in F6Publishing: 215] [Article Influence: 18.3] [Reference Citation Analysis]
212 Naume B, Johnsen AC, Espevik T, Sundan A. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur J Immunol 1993;23:1831-8. [PMID: 7688307 DOI: 10.1002/eji.1830230815] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 1.9] [Reference Citation Analysis]
213 Colotta F, Orlando S, Fadlon EJ, Sozzani S, Matteucci C, Mantovani A. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J Exp Med 1995;181:2181-6. [PMID: 7760005 DOI: 10.1084/jem.181.6.2181] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 2.1] [Reference Citation Analysis]
214 Dunn DL. Endotoxin Antagonists. In: Baue AE, Faist E, Fry DE, editors. Multiple Organ Failure. New York: Springer; 2000. pp. 492-500. [DOI: 10.1007/978-1-4612-1222-5_48] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
215 Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen W, Shou Z, Liu P. Tissue Expression and Immunolocalization of Tumor Necrosis Factor-α in Postinfarction Dysfunctional Myocardium. Circulation 1999;99:1492-8. [DOI: 10.1161/01.cir.99.11.1492] [Cited by in Crossref: 233] [Cited by in F6Publishing: 76] [Article Influence: 10.1] [Reference Citation Analysis]
216 Pliyev BK, Menshikov M. Differential effects of the autophagy inhibitors 3-methyladenine and chloroquine on spontaneous and TNF-α-induced neutrophil apoptosis. Apoptosis 2012;17:1050-65. [PMID: 22638980 DOI: 10.1007/s10495-012-0738-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
217 Köhl J, Bitter-suermann D. Anaphylatoxins. In: Whaley K, Loos M, Weiler JM, editors. Complement in Health and Disease. Dordrecht: Springer Netherlands; 1993. pp. 299-324. [DOI: 10.1007/978-94-011-2214-6_11] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
218 Shenoy S, Murawski S, Divan K, Cullin J, Mousa S, Taheri SA. Diagnosis of Pulmonary Embolism by Use of Urinary TNFα and its Soluble TNF Receptor I. Angiology 1999;50:703-6. [DOI: 10.1177/000331979905000902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
219 Van Kooten C, Banchereau J. CD40-CD40 ligand: a multifunctional receptor-ligand pair. Adv Immunol 1996;61:1-77. [PMID: 8834494 DOI: 10.1016/s0065-2776(08)60865-2] [Cited by in Crossref: 222] [Cited by in F6Publishing: 55] [Article Influence: 8.5] [Reference Citation Analysis]
220 Bufler P, Stiegler G, Schuchmann M, Hess S, Krüger C, Stelter F, Eckerskorn C, Schütt C, Engelmann H. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur J Immunol 1995;25:604-10. [DOI: 10.1002/eji.1830250244] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 2.9] [Reference Citation Analysis]
221 Metkar SS, Naresh K, Manna PP, Srinivas V, Advani S, Nadkarni J. Circulating levels of TNF? and TNF receptor superfamily members in lymphoid neoplasia. Am J Hematol 2000;65:105-10. [DOI: 10.1002/1096-8652(200010)65:2<105::aid-ajh3>3.0.co;2-r] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
222 Pandiella A, Bosenberg M, Huang E, Besmer P, Massagué J. Cleavage of membrane-anchored growth factors involves distinct protease activities regulated through common mechanisms. Journal of Biological Chemistry 1992;267:24028-33. [DOI: 10.1016/s0021-9258(18)35940-4] [Cited by in Crossref: 67] [Article Influence: 2.2] [Reference Citation Analysis]
223 Meekins JW, McLaughlin PJ, West DC, McFadyen IR, Johnson PM. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia. Clin Exp Immunol 1994;98:110-4. [PMID: 7523006 DOI: 10.1111/j.1365-2249.1994.tb06615.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 2.0] [Reference Citation Analysis]
224 Gehr G, Braun T, Lesslauer W. Cytokines, receptors, and inhibitors. Clin Investig 1992;70:64-9. [DOI: 10.1007/bf00422944] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
225 Scherübl C, Schneider-Brachert W, Schütze S, Hehlgans T, Männel DN. Colocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type 2. J Inflamm (Lond) 2005;2:7. [PMID: 15996269 DOI: 10.1186/1476-9255-2-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
226 Aso H, Yoshite O, Tomioka Y, Rose MT, Mizugaki M. A 63 kDa tumor necrosis factor inhibitor released from a human monocytic leukemia cell line, THP-1. Microbiol Immunol 1999;43:53-9. [PMID: 10100747 DOI: 10.1111/j.1348-0421.1999.tb02372.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
227 Higuchi M, Aggarwal B. Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies. Journal of Biological Chemistry 1992;267:20892-9. [DOI: 10.1016/s0021-9258(19)36771-7] [Cited by in Crossref: 25] [Article Influence: 0.8] [Reference Citation Analysis]
228 Jiménez-Gallo D, de la Varga-Martínez R, Ossorio-García L, Albarrán-Planelles C, Rodríguez C, Linares-Barrios M. The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa. Mediators Inflamm 2017;2017:2450401. [PMID: 28769536 DOI: 10.1155/2017/2450401] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
229 Yamaguchi M, Michishita M, Hirayoshi K, Yasukawa K, Okuma M, Nagata K. Down-regulation of interleukin 6 receptors of mouse myelomonocytic leukemic cells by leukemia inhibitory factor. Journal of Biological Chemistry 1992;267:22035-42. [DOI: 10.1016/s0021-9258(18)41631-6] [Cited by in Crossref: 10] [Article Influence: 0.3] [Reference Citation Analysis]
230 Bemelmans MH, Gouma DJ, Buurman WA. Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine 1994;6:608-15. [PMID: 7893969 DOI: 10.1016/1043-4666(94)90048-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
231 Costa GN, Vindeirinho J, Cavadas C, Ambrósio AF, Santos PF. Contribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose. Mol Cell Neurosci 2012;50:113-23. [PMID: 22522145 DOI: 10.1016/j.mcn.2012.04.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
232 Pruessmeyer J, Ludwig A. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Seminars in Cell & Developmental Biology 2009;20:164-74. [DOI: 10.1016/j.semcdb.2008.09.005] [Cited by in Crossref: 153] [Cited by in F6Publishing: 152] [Article Influence: 11.8] [Reference Citation Analysis]
233 Salmon JE, Millard SS, Brogle NL, Kimberly RP. Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest 1995;95:2877-85. [PMID: 7769129 DOI: 10.1172/JCI117994] [Cited by in Crossref: 89] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
234 Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG, Simonini G, Cimaz R. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): State of the art and future perspectives. Autoimmunity Reviews 2012;12:38-43. [DOI: 10.1016/j.autrev.2012.07.020] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 6.2] [Reference Citation Analysis]
235 von Baehr V, Döcke WD, Plauth M, Liebenthal C, Küpferling S, Lochs H, Baumgarten R, Volk HD. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut. 2000;47:281-287. [PMID: 10896923 DOI: 10.1136/gut.47.2.281] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 2.3] [Reference Citation Analysis]
236 Coyne CP, Moritz JT, Langston VC. Semi-synthesis of polymyxin-B conjugated ovalbumin: evaluation of lipopolysaccharide binding avidity and neutralization of induced tnf-alpha synthesis. Biotherapy 1994;8:69-83. [PMID: 7547083 DOI: 10.1007/BF01878123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
237 Matsumoto M, Seya T, Nagasawa S. Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement. Biochem J 1992;281 ( Pt 2):493-9. [PMID: 1736895 DOI: 10.1042/bj2810493] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 0.9] [Reference Citation Analysis]
238 Rose-John S, Heinrich PC. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 1994;300 ( Pt 2):281-90. [PMID: 8002928 DOI: 10.1042/bj3000281] [Cited by in Crossref: 547] [Cited by in F6Publishing: 538] [Article Influence: 19.5] [Reference Citation Analysis]
239 Schlondorff J, Blobel C. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. Journal of Cell Science 1999;112:3603-17. [DOI: 10.1242/jcs.112.21.3603] [Cited by in Crossref: 277] [Cited by in F6Publishing: 209] [Article Influence: 12.0] [Reference Citation Analysis]
240 Lewko WM, Oldham RK. Cytokines. In: Oldham RK, Dillman RO, editors. Principles of Cancer Biotherapy. Dordrecht: Springer Netherlands; 2009. pp. 155-276. [DOI: 10.1007/978-90-481-2289-9_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
241 Redl H, Schlag G, Adolf GR, Natmessnig B, Davies J. Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia. Infect Immun 1995;63:297-300. [DOI: 10.1128/iai.63.1.297-300.1995] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
242 Raina N, Lamarre J, Liew CC, Lofti AH, Jeejeebhoy KN. Effect of nutrition on tumor necrosis factor receptors in weight-gaining and -losing rats. Am J Physiol 1999;277:E464-73. [PMID: 10484358 DOI: 10.1152/ajpendo.1999.277.3.E464] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
243 Kern WV, Engel A, Schieffer S, Prümmer O, Kern P. Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis. Infect Immun 1993;61:5413-6. [DOI: 10.1128/iai.61.12.5413-5416.1993] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
244 Keith ME, Norwich KH, Jeejeebhoy KN. Nutrition Support Affects the Distribution and Organ Uptake of Cachectin/ Tumor Necrosis Factor in Rats. JPEN J Parenter Enteral Nutr 2016;19:341-50. [DOI: 10.1177/0148607195019005341] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
245 Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997;85:766-82. [PMID: 9322454 DOI: 10.1097/00000539-199710000-00011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 50] [Article Influence: 0.8] [Reference Citation Analysis]
246 Steinshamn S, Brekke O, Waage A. Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever. British Journal of Haematology 1995;89:719-24. [DOI: 10.1111/j.1365-2141.1995.tb08407.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
247 del Pozo MA, Pulido R, Muñoz C, Alvarez V, Humbría A, Campanero MR, Sánchez-madrid F. Regulation of ICAM-3 (CD50) membrane expression on human neutrophils through a proteolytic shedding mechanism. Eur J Immunol 1994;24:2586-94. [DOI: 10.1002/eji.1830241104] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
248 Chowers Y, Sturm A, Sans M, Papadakis K, Gazouli M, Harbord M, Jahnel J, Mantzaris GJ, Meier J, Mottet C. Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns Colitis. 2010;4:367-376. [PMID: 21122531 DOI: 10.1016/j.crohns.2010.05.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
249 Williams LM, Gibbons DL, Gearing A, Maini RN, Feldmann M, Brennan FM. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures. J Clin Invest 1996;97:2833-41. [PMID: 8675695 DOI: 10.1172/JCI118739] [Cited by in Crossref: 90] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
250 Itzhaky D, Raz N, Hollander N. The Glycosylphosphatidylinositol-Anchored Form and the Transmembrane Form of CD58 Are Released from the Cell Surface upon Antibody Binding. Cellular Immunology 1998;187:151-7. [DOI: 10.1006/cimm.1998.1323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
251 Rothe G, Kellermann W, Briegel J, Schaerer B, Valet G. Activation of Neutrophils by Tumor Necrosis Factor-α During Sepsis. In: Faist E, Meakins JL, Schildberg FW, editors. Host Defense Dysfunction in Trauma, Shock and Sepsis. Berlin: Springer Berlin Heidelberg; 1993. pp. 727-35. [DOI: 10.1007/978-3-642-77405-8_94] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
252 Santolaya JL, Kugler L, Francois L, Stefano VD, Ebert GA, Wolf R, Wang B, Santolaya-Forgas J. Baseline TNFα operational capacity in fetal and maternal circulation prior to the onset of labor: "tuned for different purposes". Reprod Sci 2013;20:838-44. [PMID: 23287097 DOI: 10.1177/1933719112468953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
253 Wang YF, Wu XN, Wu Q, Zhang XQ, Chen XF, Zhou XH, Wen WQ, Chen MY. Biological significance of serum soluble tumor necrosis factor receptor I in hepatoma patients. World J Gastroenterol 1996; 2(2): 89-91 [DOI: 10.3748/wjg.v2.i2.89] [Cited by in CrossRef: 1] [Article Influence: 0.0] [Reference Citation Analysis]
254 Digel W, Porzsolt F, Schmid M, Herrmann F, Lesslauer W, Brockhaus M. High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. J Clin Invest 1992;89:1690-3. [PMID: 1314854 DOI: 10.1172/JCI115769] [Cited by in Crossref: 55] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
255 Takahashi N, Brouckaert P, Bemelmans MH, Buurman WA, Fiers W. Mechanism of induction of tolerance to tumour necrosis factor (TNF): No involvement of modulators of TNF bioavailability or receptor binding. Cytokine 1994;6:235-42. [DOI: 10.1016/1043-4666(94)90018-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
256 Ossege LM, Sindern E, Patzold T, Malin JP. Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis. Int Immunopharmacol 2001;1:1085-100. [PMID: 11407304 DOI: 10.1016/s1567-5769(01)00039-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
257 Dunn DL. Diagnosis and Treatment of Infection. In: Norton JA, Bollinger RR, Chang AE, Lowry SF, Mulvihill SJ, Pass HI, Thompson RW, editors. Surgery. Berlin: Springer Berlin Heidelberg; 2001. pp. 193-219. [DOI: 10.1007/978-3-642-57282-1_11] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
258 Galon J, Aksentijevich I, Mcdermott MF, O’shea JJ, Kastner DL. TNFRSF1A mutations and autoinflammatory syndromes. Current Opinion in Immunology 2000;12:479-86. [DOI: 10.1016/s0952-7915(00)00124-2] [Cited by in Crossref: 168] [Cited by in F6Publishing: 45] [Article Influence: 7.6] [Reference Citation Analysis]
259 Piguet PF, Grau GE, de Kossodo S. Role of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Fibrosis Induced in Mice by Bleomycin. Experimental Lung Research 2009;19:579-87. [DOI: 10.3109/01902149309031729] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
260 Migaki GI, Kahn J, Kishimoto TK. Mutational analysis of the membrane-proximal cleavage site of L-selectin: relaxed sequence specificity surrounding the cleavage site. J Exp Med 1995;182:549-57. [PMID: 7543142 DOI: 10.1084/jem.182.2.549] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 3.7] [Reference Citation Analysis]
261 Angele MK, Faist E. Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care. 2002;6:298-305. [PMID: 12225603 DOI: 10.1186/cc1514] [Cited by in Crossref: 166] [Cited by in F6Publishing: 161] [Article Influence: 8.3] [Reference Citation Analysis]
262 Pogrebniak HW, Pass HI. Initial and reoperative pulmonary metastasectomy: Indications, technique, and results. Semin Surg Oncol 1993;9:142-9. [DOI: 10.1002/ssu.2980090213] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
263 Marinos G, Naoumov NV, Rossol S, Torre F, Wong PY, Gallati H, Portmann B, Williams R. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology. 1995;108:1453-1463. [PMID: 7729638 DOI: 10.1016/0016-5085(95)90694-0] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 3.3] [Reference Citation Analysis]
264 Zeman K, Kantorski J, Paleolog EM, Feldmann M, Tchórzewski H. The role of receptors for tumour necrosis factor-α in the induction of human polymorphonuclear neutrophil chemiluminescence. Immunology Letters 1996;53:45-50. [DOI: 10.1016/0165-2478(96)02613-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
265 Hachiya O, Takeda Y, Miyata H, Watanabe H, Yamashita T, Sendo F. Inhibition by Bacterial Lipopolysaccharide of Spontaneous and TNF-α-Induced Human Neutrophil Apoptosis In Vitro. Microbiology and Immunology 1995;39:715-23. [DOI: 10.1111/j.1348-0421.1995.tb03247.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
266 Chaudry IH, Ertel W, Ayala A. Alterations in Inflammatory Cytokine Production Following Hemorrhage and Resuscitation. In: Schlag G, Redl H, Traber D, editors. Shock, Sepsis, and Organ Failure. Berlin: Springer Berlin Heidelberg; 1993. pp. 73-127. [DOI: 10.1007/978-3-642-77420-1_5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
267 Loeb JA, Susanto ET, Fischbach GD. The neuregulin precursor proARIA is processed to ARIA after expression on the cell surface by a protein kinase C-enhanced mechanism. Mol Cell Neurosci 1998;11:77-91. [PMID: 9608535 DOI: 10.1006/mcne.1998.0676] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 2.0] [Reference Citation Analysis]
268 Nagaraju K, Rawat R, Veszelovszky E, Thapliyal R, Kesari A, Sparks S, Raben N, Plotz P, Hoffman EP. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. Am J Pathol 2008;172:774-85. [PMID: 18276788 DOI: 10.2353/ajpath.2008.070327] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 6.6] [Reference Citation Analysis]
269 Francés R, Chiva M, Sánchez E, González-Navajas JM, Llovet T, Zapater P, Soriano G, Muñoz C, Balanzó J, Pérez-Mateo M, Song XY, Guarner C, Such J. Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites. J Hepatol 2007;46:797-803. [PMID: 17321632 DOI: 10.1016/j.jhep.2006.11.018] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
270 Liu S, Rong L, Deng J, Zhao X, Liu X, Xu X, Qin Z. TNFR2 expression on non-bone marrow-derived cells is crucial for lipopolysaccharide-induced septic shock and downregulation of soluble TNFR2 level in serum. Cell Mol Immunol 2011;8:164-71. [PMID: 21258364 DOI: 10.1038/cmi.2010.79] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
271 Pandiella A, Massagué J. Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process. Proc Natl Acad Sci U S A 1991;88:1726-30. [PMID: 2000380 DOI: 10.1073/pnas.88.5.1726] [Cited by in Crossref: 143] [Cited by in F6Publishing: 147] [Article Influence: 4.6] [Reference Citation Analysis]
272 Malejczyk J, Malejczyk M, Breitburd F, Majewski S, Schwarz A, Expert-Besançon N, Jablonska S, Orth G, Luger TA. Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor. Br J Cancer 1996;74:234-9. [PMID: 8688327 DOI: 10.1038/bjc.1996.343] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
273 Pocsik E, Mihalik R, Penzes M, Loetscher H, Gallati H, Aggarwal BB. Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors. J Cell Biochem 1995;59:303-16. [PMID: 8567749 DOI: 10.1002/jcb.240590303] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
274 Van Leenen D, Van Der Poll T, Van Deventer SJH. Tumor necrosis factor. Induction and biological effects in humans. In: van Furth R, editor. Mononuclear Phagocytes. Dordrecht: Springer Netherlands; 1992. pp. 346-54. [DOI: 10.1007/978-94-015-8070-0_46] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
275 Austgulen R, Liabakk N, Brockhaus M, Espevik T. Soluble TNF receptors in amniotic fluid and in urine from pregnant women. Journal of Reproductive Immunology 1992;22:105-16. [DOI: 10.1016/0165-0378(92)90009-s] [Cited by in Crossref: 39] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
276 Christman JW. Potential treatment of sepsis syndrome with cytokine-specific agents. Chest 1992;102:613-7. [PMID: 1643955 DOI: 10.1378/chest.102.2.613] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
277 Pierre BAS, Granger DA, Wong JL, Merrill JE. A Study on Tumor Necrosis Factor, Tumor Necrosis Factor Receptors, and Nitric Oxide in Human Fetal Glial Cultures. Nitric Oxide - Biochemistry, Molecular Biology, and Therapeutic Implications. Elsevier; 1995. pp. 415-38. [DOI: 10.1016/s1054-3589(08)61101-1] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
278 Shepherd VL. Cytokine Receptors of the Lung. Am J Respir Cell Mol Biol 1991;5:403-10. [DOI: 10.1165/ajrcmb/5.5.403] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
279 Pham CT. Neutrophil serine proteases fine-tune the inflammatory response. Int J Biochem Cell Biol 2008;40:1317-33. [PMID: 18180196 DOI: 10.1016/j.biocel.2007.11.008] [Cited by in Crossref: 148] [Cited by in F6Publishing: 134] [Article Influence: 9.9] [Reference Citation Analysis]
280 Porteu F, Brockhaus M, Wallach D, Engelmann H, Nathan C. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. Journal of Biological Chemistry 1991;266:18846-53. [DOI: 10.1016/s0021-9258(18)55141-3] [Cited by in Crossref: 108] [Article Influence: 3.5] [Reference Citation Analysis]
281 Hanck C, Rossol S, Singer MV. Immunological changes of mild acute pancreatitis in late-stage alcoholic chronic pancreatitis. Dig Dis Sci 1999;44:1768-73. [PMID: 10505712 DOI: 10.1023/a:1018822101845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
282 Rogy MA, Oldenburg HS, Coyle S, Trousdale R, Moldawer LL, Lowry SF. Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. Br J Surg 1996;83:396-400. [PMID: 8665205 DOI: 10.1002/bjs.1800830333] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
283 Sozzani S, Locati M, Allavena P, Van Damme J, Mantovani A. Chemokines: a superfamily of chemotactic cytokines. Int J Clin Lab Res 1996;26:69-82. [PMID: 8856360 DOI: 10.1007/BF02592349] [Cited by in Crossref: 66] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
284 Bao L, Lindgren J, Zhu Y, Ljunggren H, Zhu J. Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis. Neurobiology of Disease 2003;12:73-81. [DOI: 10.1016/s0969-9961(02)00007-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
285 Winkler O, Hadnagy W, Idel H. Cytokines detectable in saliva of children as appropriate markers of local immunity of the oral cavity--an approach for the use in air pollution studies. Int J Hyg Environ Health 2001;204:181-4. [PMID: 11759162 DOI: 10.1078/1438-4639-00092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
286 Kallinowski B, Haseroth K, Marinos G, Hanck C, Stremmel W, Theilmann L, Singer MV, Rossol S. Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol. 1998;111:269-277. [PMID: 9486392 DOI: 10.1046/j.1365-2249.1998.00469.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 3.3] [Reference Citation Analysis]
287 Kemper O, Wallach D. Cloning and partial characterization of the promoter for the human p55 tumor necrosis factor (TNF) receptor. Gene 1993;134:209-16. [DOI: 10.1016/0378-1119(93)90095-k] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
288 Spapen H, Zhang H, Demanet C, Vleminckx W, Vincent JL, Huyghens L. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest 1998;113:1616-24. [PMID: 9631802 DOI: 10.1378/chest.113.6.1616] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 3.7] [Reference Citation Analysis]
289 Salamone G, Trevani A, Martínez D, Vermeulen M, Gamberale R, Fernández-Calotti P, Raiden S, Giordano M, Geffner J. Analysis of the mechanisms involved in the stimulation of neutrophil apoptosis by tumour necrosis factor-alpha. Immunology 2004;113:355-62. [PMID: 15500622 DOI: 10.1111/j.1365-2567.2004.01973.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]